Unraveling the Interplay of p21, Autophagy, and Mitophagy in Mitigating Skeletal Muscle Dysfunction during Aging and Obesity

Introduction: The accumulation of senescent cells accelerates aging, a process further exacerbated by obesity. The decline of muscle function is a hallmark of this progression due to muscle atrophy stemming from dysregulated autophagy and mitochondrial function in skeletal muscles. p21 is one of the major regulators, which accumulates in tissues with aging and obesity. Previous studies have demonstrated that the elimination of p21-highly-expressing ( p21 high ) cells improves muscle function. However, the connection between p21 and its influence on muscle function remains unclear. One possible explanation is associated with alternations in autophagy and mitophagy through mitochondria dysfunction and increased reactive oxygen species. Therefore, this study investigated the link between autophagy, mitophagy, and p21 in the context of aging and obesity. Methods: Four 18-month-old male p21-Cre/+; +/+ (P) and p21-Cre/+; DTA/+ (PD) mice, fed by high-fat diet for 15 months were administered with tamoxifen for twice. We previously observed the P group with accumulation of p21 high cells, which were effectively eliminated in PD group. Soleus muscles were collected for subsequent immunoblotting analysis, employing primary antibodies targeting key proteins involved in autophagy and mitophagy cellular processes. Results: Our study elucidates dynamic changes driven by eliminating p21 high cells in autophagy and mitophagy marker levels within the soleus muscles of mice exposed to a high-fat diet for 15 months. There was no significant difference in the body weight of P and PD mice (65.1±2.58 g vs. 64.3±2.22 g). In P mice, an increase in the upstream autophagy initiator, Beclin1, was observed, along with elevated levels of ATG4A, ATG7, and the ATG12-ATG5 complex, indicating elongation of autophagosome formation. Despite increased autophagosome marker p62, the LC3-II/LC3-I ratio remained unchanged. Lysosomal markers, LAMP1 and LAMP2, were both elevated in P mice. Conversely, PD mice exhibited heightened mitochondrial damage elimination markers, Parkin, VDAC1, and DRP1. Although PINK1 levels were not significantly changed, they showed an increasing trend. Conclusion: Our results suggest that eliminating p21 high cells may be the potential therapeutic approach to enhance skeletal muscle function in the context of obesity and aging, possibly through autophagy and mitophagy. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.